WhichRecall
Class IIReported 2025-07-02

Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, 15 mL, Rx Only, Sterile, Manufactured by: Apotex Inc., Toronto, Ontario, Canada, M9L 1T9, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-0589-3

Recalled by Apotex Corp.

Reason for Recall

Lack of Assurance of Sterility

Advertisement
Recall Number
D-0496-2025
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2025-05-28
Reported
2025-07-02
Distribution
US Nationwide.
Code Info
Batch VC6058, Exp Date: 10/31/2025
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement